UK markets open in 6 hours 30 minutes

MERCK KGAA O.N. (MRK.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
128.00+3.50 (+2.81%)
At close: 5:29PM CEST
Full screen
Previous close124.50
Open123.80
Bid0.00 x 0
Ask0.00 x 0
Day's range123.80 - 128.00
52-week range77.20 - 131.30
Volume4
Avg. volume27
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
Press releases
  • EQS Group

    Merck KGaA: Merck KGaA reverses provision for lawsuit in the amount of EUR 365 million

    Merck KGaA / Key word(s): MiscellaneousMerck KGaA: Merck KGaA reverses provision for lawsuit in the amount of EUR 365 million29-Sep-2020 / 18:06 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Darmstadt, September 29, 2020. In the United States Merck KGaA's subsidiary EMD Serono, Inc. (Merck) is involved in a US patent dispute with Biogen Inc., United States (Biogen). Biogen sued Merck for damages in connection with a patent infringement caused by Merck's product Rebif before the U.S. District Court New Jersey, Newark. Merck defended itself against the allegations and brought a countersuit claiming that Biogen's patent is invalid. In February 2018 a jury declared Biogen's patent invalid vis-à-vis Merck. The jury verdict was overturned by the District Court Judge, who upheld the validity of Biogen's patent. Merck filed a complaint with the U.S. Court of Appeals for the Federal Circuit against this ruling.On 28 September 2020 the U.S. Court of Appeals for the Federal Circuit set aside the decision of the District Court Judge, invalidated Biogen's patent and instructed the District Court to reinstate the jury verdict.Therefore, Merck KGaA has decided today to reverse the provisions for the patent dispute proceedings in the amount of EUR 365 million. Thereof, up to a mid to high double-digit million amount might be booked into the financial result.Merck KGaA will adjust its forecasts accordingly as part of its regular financial reportingFriederike Segeberg, Leiterin News & ReputationMerck KGaAFrankfurter Straße 25064293 DarmstadtGermanyPhone: +49 6151 72 - 6328Fax: +49 6151 72 - 913321Email: investor.relations@merckgroup.comInternet: www.merck.deISIN: DE0006599905WKN: 659990Indices: DAXStock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX29-Sep-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: Merck KGaA Frankfurter Str. 250 64293 Darmstadt Germany Phone: +49 (0)6151 72 - 6328 E-mail: Friederike.Segeberg@merckgroup.com Internet: https://www.merckgroup.com/de ISIN: DE0006599905 WKN: 659990 Indices: DAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX EQS News ID: 1137699   End of Announcement DGAP News Service

  • EQS Group

    Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

    Merck KGaA 09.04.2020 / 13:26 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1\. Details of issuer Name: Merck KGaA Street: Frankfurter Str. 250 Postal code: 64293 City: Darmstadt Germany Legal Entity Identifier (LEI): 529900OAREIS0MOPTW25 2\. Reason for notification X Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights X Other reason: voluntary group notification with triggered threshold on subsidiary level: rise over 3% 3\. Details of person subject to the notification obligation Legal entity: Amundi S.A. City of registered office, country: Paris, France 4\. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5\. Date on which threshold was crossed or reached: 06 Apr 2020 6\. Total positions % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 3.48 % 0.002 % 3.48 % 129242252 Previous notification 3.02 % 0.002 % 3.02 % / 7\. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE0006599905 4501916 % 3.48 % Total 4501916 3.48 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % security lending (right to recall) n/a n/a 2113 0.002 % Total 2113 0.002 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % % Total % 8\. Information in relation to the person subject to the notification obligation Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) Amundi S.A. % % % Amundi Asset Management S.A.S. 3.04 % % % Amundi S.A. % % % CPR AM % % % Amundi S.A. % % % Etoile Gestion % % % Amundi S.A. % % % Societe Generale Gestion % % % Amundi S.A. % % % Amundi Asset Management S.A.S. 3.04 % % % Amundi Singapore Ltd. % % % Amundi S.A. % % % Amundi Asset Management S.A.S. 3.04 % % % Amundi Iberia SGIIC, SA. % % % Amundi S.A. % % % Amundi Asset Management S.A.S. 3.04 % % % Amundi Japan Holding Ltd. % % % Amundi Japan Ltd. % % % 9\. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: Proportion of voting rights Proportion of instruments Total of both % % % 10\. Other explanatory remarks: Date 08 Apr 2020 * * *09.04.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: Merck KGaA Frankfurter Str. 250 64293 Darmstadt Germany Internet: www.merck.de End of News DGAP News Service